We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+0.54%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+561.69%
AUM
$235B
AUM Growth
+$14.9B
Cap. Flow
+$12.9B
Cap. Flow %
5.48%
Top 10 Hldgs %
23.67%
Holding
10,941
New
1,599
Increased
4,693
Reduced
3,596
Closed
888

Sector Composition

Rank Sector Weight
1 Technology 3.09%
2 Consumer Discretionary 2.15%
3 Financials 1.67%
4 Healthcare 1.64%
5 Communication Services 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNN icon
9901
PUT
Denison Mines
DNN
$3.39B
$30K ﹤0.01%
39,800
+5,500
+16% +$4.64K
GURE
9902
CALL
Gulf Resources
GURE
$5.71M
$30K ﹤0.01%
288
-84
-23% -$9.87K
SEEL
9903
PUT
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
0
ASXC
9904
DELISTED
Asensus Surgical, Inc.
ASXC
$30K ﹤0.01%
+776
New +$35.7K
ONCT
9905
PUT
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$30K ﹤0.01%
15
+3
+25% +$4.26K
ALBO
9906
DELISTED
Albireo Pharma Inc
ALBO
$30K ﹤0.01%
956
-19
-2% -$638
OIBR
9907
DELISTED
OI S A SPONSORED ADR REPSTG PFD NEW (BRA)
OIBR
$30K ﹤0.01%
15,880
ANAD
9908
DELISTED
ANADIGICS INC
ANAD
$30K ﹤0.01%
+40,571
New +$41.9K
WHZ
9909
CALL
DELISTED
WHITING USA TR II TR UNIT (DE)
WHZ
$30K ﹤0.01%
11,800
-22,200
-65% -$96.8K
SOL
9910
PUT
DELISTED
Emeren Group
SOL
$29K ﹤0.01%
4,260
-3,020
-41% -$23.8K
ONCT
9911
CALL
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$29K ﹤0.01%
14
+3
+27% +$4.26K
BIOC
9912
PUT
DELISTED
Biocept, Inc.
BIOC
0
VMEM
9913
PUT
DELISTED
VIOLIN MEMORY, INC.
VMEM
$29K ﹤0.01%
2,925
-2,225
-43% -$29.2K
PCO
9914
DELISTED
Pendrell Corporation - Class A
PCO
$29K ﹤0.01%
+21
New +$24.7K
NPD
9915
PUT
DELISTED
CHINA NEPSTAR CHAIN DRUGSTORE LTD. COM
NPD
$29K ﹤0.01%
+12,500
New +$32.2K
ANR
9916
PUT
DELISTED
Alpha Natural Resources Inc
ANR
$29K ﹤0.01%
88,700
-127,700
-59% -$87.9K
GYRE icon
9917
CALL
Gyre Therapeutics
GYRE
$706M
$28K ﹤0.01%
13
-30
-70% -$60.1K
FNCX
9918
DELISTED
Function(x) Inc.
FNCX
$28K ﹤0.01%
+686
New +$31.5K
IKGH
9919
PUT
DELISTED
Iao Kun Group Holding Company Limited
IKGH
$28K ﹤0.01%
+12,400
New +$24.9K
EXTR icon
9920
CALL
Extreme Networks
EXTR
$2.96B
$27K ﹤0.01%
10,000
-8,400
-46% -$22.7K
LTBR icon
9921
Lightbridge
LTBR
$304M
$27K ﹤0.01%
397
-76
-16% -$5.87K
TRAW icon
9922
PUT
Traws Pharma
TRAW
$8.72M
0
AVEO
9923
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$27K ﹤0.01%
1,563
-8,547
-85% -$154K
RIBTW
9924
DELISTED
RiceBran Technologies - Warrant
RIBTW
$27K ﹤0.01%
26,333
WINT
9925
DELISTED
Windtree Therapeutics Inc
WINT
$27K ﹤0.01%
+2,889
New +$40.6K

Similar funds

Jeff Yass's Q2 2015 Portfolio in Review

As of Q2 2015, Jeff Yass held 10,941 positions worth $235B, up 6.8% from $220B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Jeff Yass deployed $12.9B of net new capital in Q2 2015, opening 1,599 new positions and adding to 4,693 existing holdings. Its largest new stake was Vanguard Global ex-US Real Estate ETF: 1,789,597 shares worth $99.3M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 3% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.17B trimmed.

  • Jeff Yass's largest Q2 2015 buy was Vanguard Global ex-US Real Estate ETF: 1,789,597 shares worth $99.3M.
  • Jeff Yass added most to Alphabet (Google) Class C in Q2 2015, an estimated $726M increase.
  • Jeff Yass's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.17B.
  • Jeff Yass fully exited ACTAVIS PLC Pfd Conv Ser A (Irl) in Q2 2015, selling an estimated $41.7M.
  • Jeff Yass's ten largest holdings make up 24% of its $235B portfolio in Q2 2015.
  • Jeff Yass opened 1,599 new positions and closed 888 in Q2 2015.
  • Jeff Yass's portfolio value rose 6.8% quarter-over-quarter to $235B.

Based on Susquehanna International Group's 13F filing for Q2 2015, filed 14 Aug 2015.